金安國紀(002636.SZ)董事會同意成立醫藥事業部
格隆匯2月19日丨金安國紀(002636.SZ)公佈,公司第四屆董事會第十六次會議審議通過了《關於成立醫藥事業部的議案》,同意公司成立醫藥事業部。
保證覆銅板主業穩步增長,圍繞醫療健康領域的內生與外延並重的發展方式推進醫療健康事業的發展,形成公司業務雙軌制發展的運行機制和複合發展模式,提升公司綜合競爭力,是公司現階段的發展戰略。公司成立醫藥事業部,有利於公司在醫療健康領域投資併購的管理、整合和提升。有利於公司醫療健康類各子公司的融合發展,迅速適應統一規範化管理。有利於公司整合公司資源,形成集團化管理體系。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.